GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » Change In Payables And Accrued Expense

Synbio Tech (ROCO:1295) Change In Payables And Accrued Expense : NT$0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Synbio Tech Change In Payables And Accrued Expense?

Synbio Tech's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was NT$0.0 Mil. It means Synbio Tech's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Synbio Tech's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was NT$0.0 Mil. It means Synbio Tech's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Synbio Tech Change In Payables And Accrued Expense Historical Data

The historical data trend for Synbio Tech's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synbio Tech Change In Payables And Accrued Expense Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Change In Payables And Accrued Expense
- - - - -

Synbio Tech Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Synbio Tech Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Synbio Tech's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Synbio Tech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
ROCO:6676 ROCO:6846 ROCO:4168 TPE:1762 ROCO:6748 ROCO:7754 TPE:4133 TPE:3164 ROCO:6704 ROCO:4130 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No.66, Beiling 6th Road, Luzhu District, Kaohsiung, TWN
Website
https://www.synbiotech.com
Synbio Tech Inc is a company specializing in the research, manufacturing, and application development of lactic acid bacteria. The company provides lactic acid bacteria screening, functional research and verification, and the introduction of advanced processes to produce safe and stable high-quality bacterial powder, OEM, ODM customized finished products, share application development technology, provide excellent service quality, and gain recognition from customers.

Synbio Tech Headlines

No Headlines